Filter
9099
Filtered Results: 9099
Text search:
country
health
report
Featured
Recommendations
670
New Publications
2537
Language
Document type
No document type
5322
Studies & Reports
1755
Guidelines
866
Manuals
375
Strategic & Response Plan
330
Fact sheets
163
Situation Updates
116
Training Material
115
Resource Platforms
25
Infographics
14
Brochures
12
Online Courses
4
Dashboards/Maps
1
App
1
Countries / Regions
India
380
Global
368
Kenya
320
Ethiopia
220
Sierra Leone
212
Uganda
201
Liberia
195
Western and Central Europe
185
Nigeria
184
Nepal
180
Myanmar / Burma
173
South Africa
164
Zambia
148
Rwanda
146
Latin America and the Carribbean
138
Malawi
137
Bangladesh
135
Ghana
128
Africa
127
Syria
126
Tanzania
126
Ukraine
113
Congo, Democratic Republic of
91
Philippines
76
Namibia
73
South Sudan
71
Lesotho
71
Senegal
66
Eastern Europe
66
Zimbabwe
65
Mozambique
65
Cambodia
61
Indonesia
59
Asia
59
Venezuela
59
Guinea
58
South–East Asia Region
58
Yemen
57
Haiti
55
Burkina Faso
50
West and Central Africa
47
Botswana
44
Cameroon
43
East and Southern Africa
42
Brazil
38
Russia
38
Germany
37
Pakistan
36
Colombia
36
Afghanistan
34
Middle East and North Africa
33
Eswatini/ Swaziland
31
Eastern Europe and Central Asia
31
Central African Republic
27
Benin
26
Lebanon
25
Madagascar
25
Mali
24
Jordan
23
Somalia
22
Sudan
21
Thailand
20
Tajikistan
19
Côte d’Ivoire / Ivory Coast
16
Peru
16
Western Pacific Region
16
China
15
Albania
15
Moldova
15
Vietnam
15
Iraq
13
Paraguay
13
Sri Lanka
12
Georgia
12
USA
11
Togo
11
Turkey
11
Argentina
11
Laos
11
Papua New Guinea
10
North Macedonia
10
Niger
9
Ecuador
9
Chile
9
Bolivia
8
Greece
8
Libya
8
Angola
8
Palestine
8
Southern Africa
8
Iran
8
Kyrgyzstan
8
North America
8
Guinea-Bissau
7
Egypt
7
Burundi
7
Poland
7
Armenia
7
Chad
6
Hungary
6
Mexico
6
Bhutan
6
Romania
6
Jamaica
6
Gambia
5
El Salvador
5
Timor Leste/ East Timor
5
Kazakhstan
5
Portugal
5
Spain
5
Malaysia
4
Serbia
4
Honduras
4
Turkmenistan
4
Tunisia
4
United Kingdom
4
Belarus
4
Morocco
3
Saudi Arabia
3
Croatia
3
Guatemala
3
Italy
3
Djibouti
3
Uzbekistan
3
Japan
3
France
3
Mauritius
3
Bosnia and Herzegovina
3
Mauritania
2
Singapore
2
Dominican Republic
2
Nicaragua
2
Congo-Brazzaville
2
Canada
2
Qatar
2
Bulgaria
2
Estonia
2
Lithuania
2
Slovakia
2
Gabon
2
Azerbaijan
2
Israel
2
Ireland
1
Vanuatu
1
Other region
1
Fiji
1
Solomon Islands
1
North Korea
1
Mongolia
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3706
Clinical Guidelines
542
Public Health
469
Women & Child Health
443
Key Resources
399
Capacity Building
142
Pharmacy & Technologies
77
Annual Report MEDBOX
3
Protection & Security
2
General Guidelines
1
Toolboxes
HIV
709
COVID-19
670
Mental Health
635
TB
457
Disability
382
Planetary Health
334
Conflict
300
Ebola
268
Rapid Response
265
AMR
254
NTDs
203
Caregiver
198
Refugee
192
Global Health Education
154
Pharmacy
150
NCDs
147
Health Financing Toolbox
114
Natural Hazards
113
Polio
54
Cholera
52
Zika
51
Specific Hazards
38
Social Ethics
21
Typhoon
7
Health Financing
3
South Sudan
2
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
An overview of validation structures and responsibilities at national, regional and global levels.
This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
On September 10, 2022, the Ministry of Health (MOH) announced a cholera outbreak in Aleppo governorate with 15 laboratory confirmed cases reported between August 25 and September 9, 2022. Activities...
Cities are uniquely positioned to understand local needs and respond rapidly to changing conditions to safeguard health. These changes require strong city leadership to implement multisectoral, health...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglec...
Patient safety assessment manual
recommended
3rd edition. Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO gu...
Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO guidance. The m...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
In January 2021, the World Health Organization (WHO) published a new road map to address the burden of disease and death imposed by neglected tropical diseases (NTDs). The end of the first year of the 2021-2030 NTD road map is an opportunity to take...
